Category: Conferences & CLE’s

Technology Transfer Tactics will be offering a webinar entitled "Moving From First to Invent to First to File: Understanding the Opportunities and Challenges" on April 26, 2012 from 1:00 – 2:00 pm (Eastern).  Charles R. Macedo of Amster, Rothstein and Ebenstein, LLP will discuss the conversion to the new first-to-file system under the Leahy-Smith America…

March 20-21, 2012 – FDA Boot Camp*** (American Conference Institute) – New York, NY March 22, 2012 – The FDA's Guidance on Biosimilars: Understanding the Impact on Patent Prosecution and Litigation (Intellectual Property Owners Association) – 2:00 – 3:00 pm (ET) March 26-27, 2012 – PTO Procedures under the America Invents Act*** (American Conference Institute)…

The Biotechnology Industry Organization (BIO) will be holding its Intellectual Property Counsels Committee (IPCC) Spring Conference & Meeting on April 16-18, 2012 in Austin, TX.  The semi-annual IPCC conference will once again be open to the public. The conference will offer presentations on the following topics: Monday, April 16: • Putting The Pieces Together (Pre-Conference…

The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "The FDA's Guidance on Biosimilars: Understanding the Impact on Patent Prosecution and Litigation" on March 22, 2012 beginning at 2:00 pm (ET).  A panel consisting of Henry Hadad of Bristol-Myers Squibb Co., Erika Lietzan of Covington & Burling LLP, and Suzanne Munck of…

March 14-15, 2012 – Biotech Patenting (C5) – Munich, Germany March 20-21, 2012 – FDA Boot Camp*** (American Conference Institute) – New York, NY March 26-27, 2012 – PTO Procedures under the America Invents Act*** (American Conference Institute) – New York, NY March 27, 2012 – The Biosimilar Drug Approval Pathway: Draft FDA Guidance and…

American Conference Institute (ACI) will be holding a conference on Biosimilars on May 22-23, 2012 in New York, NY.  ACI faculty will help attendees: • Understand and comply with the FDA's current position on defining biosimilarity and demonstrating interchangeability under the abbreviated pathway;• Determine the financial viability of biosimilars and explore new strategic alliances and…

Strafford will be offering a webinar entitled "Patent Term Adjustments and Extensions: Recent Developments" on April 18, 2012 from 1:00 – 2:30 pm (EDT).  Thomas L. Irving of Finnegan Henderson Farabow Garrett & Dunner and Margaret J. Sampson of Vinson & Elkins will provide guidance to IP counsel for calculating patent term adjustments and extensions,…

Strafford will be offering a webinar entitled "Contested Proceedings Before the New Patent Trial and Appeal Board" on April 3, 2012 from 1:00 – 2:30 pm (EDT).  Scott A. McKeown and Greg H. Cardella of Oblon Spivak McClelland Maier & Neustadt will examine the new Patent Trial and Appeal Board (PTAB) and procedures for contested…

March 6, 2012 – Biotechnology/Chemical/Pharmaceutical (BCP) Customer Partnership Meeting (U.S. Patent and Trademark Office) – 9:30 am – 4:00 pm (ET) March 14-15, 2012 – Biotech Patenting (C5) – Munich, Germany March 20-21, 2012 – FDA Boot Camp*** (American Conference Institute) – New York, NY March 26-27, 2012 – PTO Procedures under the America Invents…

McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar on the "The Biosimilar Drug Approval Pathway: Draft FDA Guidance and Beyond" on March 27, 2012 from 10:00 am to 11:15 am (CT).  Patent Docs authors and MBHB attorneys Dr. Kevin Noonan and Dr. James DeGiulio will provide a detailed analysis of the…